skip to main content ↓

Multiple Sclerosis In The Crossfire 2008: The Emerging Face of MS


The Emerging Face of MS

The understanding of multiple sclerosis has come a long way since the first treatments for the disease were developed and made available in the early 1990’s. Not only do we have increased knowledge of the immune system and the pathophysiology of MS, but we also have long-term data showing the effect of disease-modifying therapy. In this year’s program, divided into 2 parts for easier viewing, Dr. Omar Khan and his panel of MS specialists will discuss emerging themes of clinical interest, including practice issues, imaging data and the next generation of MS therapeutics.

Part 1 of this lively discussion will include information on some of the latest findings about the immunopathology of MS, and updated information about the clinical effects of disease-modifying therapy. In Part 2, new data from imaging studies and consideration of the next generation of MS Therapeutics in light of current information will be the topics for discussion.

Sponsored and Supported by:

This continuing medical education activity is jointly sponsored by Ciné-Med Inc. and Astute Technology.

  • Ciné-Med
  • Astute Technology

This activity is supported by an educational grant from Teva Neuroscience.

2008 Distinguished Faculty

Omar Khan, MD, MD, Moderator

Omar Khan, MD

Moderator

Edward J. Fox, MD, PhD

Edward J. Fox, MD, PhD

Panelist

Bruce Cree, MD, PhD, MCR

Bruce Cree, MD, PhD, MCR

Panelist

Clyde E. Markowitz, MD

Clyde E. Markowitz, MD

Panelist

In The Crossfire 2007: Focus on Imaging

In 2 hours of lively discussion, four expert neurologists—3 neuroimaging specialists and a leading clinical investigator—discuss the evolution and clinical potential of magnetic resonance imaging techniques, in light of the new research gains in Multiple Sclerosis.

In The Crossfire 2007